L-glutamine (Endari)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 00:59, 7 May 2023 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pharmaceutical grade L-glutamine

Diseases for which it is used

History of changes in FDA indication

  • 2017-07-07: Approved for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

Also known as

  • Brand name: Endari
Retrieved from "https://hemonc.org/w/index.php?title=L-glutamine_(Endari)&oldid=70419"